Skip to main content
SpringerLink
Log in

Risperidone

Worsening of myasthenia gravis: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Al-Hashel JY, et al. Worsening of myasthenia gravis after administration of injectable long-acting risperidone for treatment of schizophrenia; first case report and a call for caution. Neuromuscular Disorders 26: 309-11, No. 4-5, Apr-May 2016. Available from: URL: http://doi.org/10.1016/j.nmd.2016.02.006 - Kuwait

    Article  PubMed  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Risperidone. Reactions Weekly 1635, 261 (2017). https://doi.org/10.1007/s40278-017-25510-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-017-25510-3

Search

Navigation